Insulin Receptor Knockout Mice

Annual Review of Physiology

Volumn 65, Issue , 2003, Pages 313-332

  Kitamura, Tadahiro ^a   Kahn, C Ronald ^b   Accili, Domenico ^a  

^a Columbia University ^*  (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

cell; Animal models; Diabetes; Genetics; Signal transduction

Indexed keywords

INSULIN RECEPTOR; SOMATOMEDIN C RECEPTOR;

BRAIN; CAUSE OF DEATH; CELL SPECIFICITY; CELL TYPE; DIABETES MELLITUS; EMBRYO DEVELOPMENT; GENETIC ANALYSIS; HAPLOIDY; HOMEOSTASIS; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; INSULIN METABOLISM; KETOACIDOSIS; KNOCKOUT MOUSE; METABOLIC DISORDER; MOUSE; MUTAGENESIS; NONHUMAN; PANCREAS ISLET BETA CELL; PHENOTYPE; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY; ANIMAL; ENERGY METABOLISM; GENETICS; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; ENERGY METABOLISM; MICE; MICE, KNOCKOUT; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

EID: 0037974530     PISSN: 00664278     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.physiol.65.092101.142540     Document Type: Review

References (130)

1. Saltiel AR, Kahn CR. 2001. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799-806
2. Nef S, Parada LF. 2000. Hormones in male sexual development. Genes Dev. 14:3075-86
3. Nakae J, Kido Y, Accili D. 2001. Distinct and overlapping functions of insulin and IGF-I receptors. Endocr. Rev. 22:818-35
4. Chassin D, Laurent A, Janneau JL, Berger R, Bellet D. 1995. Cloning of a new member of the insulin gene superfamily (INSL4) expressed in human placenta. Genomics 29:465-70
5. Conklin D, Lofton-Day CE, Haldeman BA, Ching A, Whitmore TE, et al. 1999. Identification of INSL5, a new member of the insulin superfamily. Genomics 60:50-56
6. Hsu SY. 1999. Cloning of two novel mammalian paralogs of relaxin/insulin family proteins and their expression in testis and kidney. Mol. Endocrinol. 13:2163-74
7. Kasik J, Muglia L, Stephan DA, Menon RK. 2000. Identification, chromosomal mapping, and partial characterization of mouse Ins16: a new member of the insulin family. Endocrinology 141:458-61
8. Lok S, Johnston DS, Conklin D, Lofton-Day CE, Adams RL, et al. 2000. Identification of INSL6, a new member of the insulin family that is expressed in the testis of the human and rat. Biol. Reprod. 62:1593-99
9. Ullrich A, Bell JR, Chen EY, Herrera R, Petruzzelli LM, et al. 1985. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 313:756-61.
10. Ebina Y, Ellis L, Jamagin K, Edery M, Graf L, et al. 1985. The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell 40:747-58
11. Ullrich A, Gray A, Tam AW, Yang FT, Tsubokawa M, et al. 1986. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J. 5:2503-12
12. Morgan DO, Edman JC, Standring DN, Fried VA, Smith MC, et al. 1987. Insulin-like growth factor II receptor as a multifunctional binding protein. Nature 329:301-7
13. Shier P, Watt VM. 1989. Primary structure of a putative receptor for a ligand of the insulin family. J. Biol. Chem. 264:14605-8
14. Wei L, Hubbard SR, Hendrickson WA, Ellis L. 1995. Expression, characterization, and crystallization of the catalytic core of the human insulin receptor protein-tyrosine kinase domain. J. Biol. Chem. 270:8122-30
15. Hubbard SR. 1997. Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J. 16:5572-81
16. Schlessinger J. 2000. Cell signaling by receptor tyrosine kinases. Cell 103:211-25
17. Efstratiadis A. 1998. Genetics of mouse growth. Int. J. Dev. Biol. 42:955-76
18. Poy MN, Yang Y, Rezaei K, Femstrom MA, Lee AD, et al. 2002. CEACAM1 regulates insulin clearance in liver. Nat. Genet. 30:270-76
19. Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, et al. 2000. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase IB-deficient mice. Mol. Cell Biol. 20:5479-89
20. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. 1996. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271:665-68
21. Louvi A, Accili D, Efstratiadis A. 1997. Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. Dev. Biol. 189:33-48
22. Bruning JC, Gautam D, Burks DJ, Gillette J, Schubert M, et al. 2000. Role of brain insulin receptor in control of body weight and reproduction. Science 289:2122-55
23. Accili D, Drago J, Lee EJ, Johnson MD, Cool MH, et al. 1996. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat. Genet. 12:106-9
24. Joshi RL, Lamothe B, Cordonnier N, Mesbah K, Monthioux E, et al. 1996. Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. EMBO J. 15:1542-47
25. Duvillie B, Cordonnier N, Deltour L, Dandoy-Dron F, Itier JM, et al. 1997. Phenotypic alterations in insulin-deficient mutant mice. Proc. Natl. Acad. Sci. USA 94:5137-40
26. Taylor SI. 1992. Lilly Lecture: molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene. Diabetes 41:1473-90
27. Wertheimer E, Lu SP, Backeljauw PF, Davenport ML, Taylor SI. 1993. Homozygous deletion of the human insulin receptor gene results in leprechaunism. Nat. Genet. 5:71-73
28. Psiachou H, Mitton S, Alaghband ZJ, Hone J, Taylor SI, Sinclair L. 1993. Leprechaunism and homozygous nonsense mutation in the insulin receptor gene. Lancet 342:924
29. Krook A, Brueton L, O'Rahilly S. 1993. Homozygous nonsense mutation in the insulin receptor gene in infant with leprechaunism. Lancet 342:277-78
30. Jospe N, Kaplowitz PB, Furlanetto RW. 1996. Homozygous nonsense mutation in the insulin receptor gene of a patient with severe congenital insulin resistance: leprechaunism and the role of the insulin-like growth factor receptor. Clin. Endocrinol. 45:229-35
31. Takahashi Y, Kadowaki H, Momomura K, Fukushima Y, Orban T, et al. 1997. A homozygous kinase-defective mutation in the insulin receptor gene in a patient with leprechaunism. Diabetologia 40:412-20
32. Taylor SI, Hedo JA, Underbill LH, Kasuga M, Elders MJ, Roth J. 1982. Extreme insulin resistance in association with abnormally high binding affinity of insulin receptors from a patient with leprechaunism: evidence for a defect intrinsic to the receptor. J. Clin. Endocrinol. Metab. 55:1108-13
33. Hone J, Accili D, Psiachou H, Alghband ZJ, Mitton S, et al. 1995. Homozygosity for a null allele of the insulin receptor gene in a patient with leprechaunism. Hum. Mutat. 6:17-22
34. Kadowaki T, Bevins CL, Cama A, Ojamaa K, Marcus-Samuels B, et al. 1988. Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance. Science 240:787-90
35. Danan C, Amselem S, Dassieu G, Cohen R, Janaud JC. 1994. Physiopathological approach and antenatal diagnosis of diabetes mellitus insulin resistance: apropos of a case with leprechaunism. Arch. Pediatr. 1:268-72
36. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72
37. Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, et al. 1999. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol. Cell Biol. 19:3278-88
38. Widdowson EM. 1950. Chemical composition of newly born mammals. Nature 166:626-28
39. Pendergrass M, Fazioni E, DeFronzo RA. 1996. Non-insulin-dependent diabetes mellitus and gestational diabetes mellitus: same disease, another name? Diabetes Rev. 3:566-83
40. Tyrala EE. 1996. The infant of the diabetic mother. Obstet. Gynecol. Clin. North. Am. 23:221-41
41. DeBaun MR, King AA, White N. 2000. Hypoglycemia in Beckwith-Wiedemann syndrome. Semin. Perinatol. 24:164-71
42. Hazeltine FG. 1967. Hypoglycemia and RH erythroblastosis fetalis. Pediatrics 39:696-99
43. Barrett CT, Oliver TK Jr. 1968. Hypoglycemia and hyperinsulinism in infants with erythroblastosis fetalis. N. Engl. J. Med. 278:1260-62
44. Reinecke-Luthge A, Koschoreck F, Kloppel G. 2000. The molecular basis of persistent hyperinsulinemic hypoglycemia of infancy and its pathologic substrates. Virchows Arch. 436:1-5
45. Kitamura T, Nakae J, Kahn C, Efstratiadis A, Accili D. 2002. Lipoatrophy, postnatal growth retardation and diabetes resulting from variable conditional inactivation of the insulin receptor gene in mice. Diabetes 51(Suppl. 2):1337 (Abstr.)
46. Lund PK, Moats-Staats BM, Hynes MA, Simmons JG, Jansen M, et al. 1986. Somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II mRNAs in rat fetal and adult tissues. J. Biol. Chem. 261:14539-44
47. DeChiara TM, Efstratiadis A, Robertson EJ. 1990. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345:78-80
48. Han VK, D'Ercole AJ, Lund PK. 1987. Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. Science 236: 193-97
49. Postic C, Shiota M, Niswender KD, Jetton TL, Chen Y, et al. 1999. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J. Biol. Chem. 274:305-15
50. Grupe A, Hultgren B, Ryan A, Ma YH, Bauer M, Stewart TA. 1995. Transgenic knockouts reveal a critical requirement for pancreatic beta cell glucokinase in maintaining glucose homeostasis. Cell 83:69-78
51. Terauchi Y, Sakura H, Yasuda K, Iwamoto K, Takahashi N, et al. 1995. Pancreatic beta-cell-specific targeted disruption of glucokinase gene. Diabetes mellitus due to defective insulin secretion to glucose. J. Biol. Chem. 270:30253-56
52. Guillam MT, Hummler E, Schaerer E, Yeh JI, Birnbaum MJ, et al. 1997. Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2. Nat. Genet. 17:327-30
53. She P, Shiota M, Shelton KD, Chalkley R, Postic C, Magnuson MA. 2000. Phosphoenolpyruvate carboxykinase is necessary for the integration of hepatic energy metabolism. Mol. Cell Biol. 20:6508-17
54. Accili D, Kido Y, Nakae J, Lauro D, Park B-C. 2001. Genetics of type 2 diabetes: insights from targeted mouse mutants. Curr. Mol. Med. 1:9-23
55. Bier DM, Schedewie H, Lamer J, Olefsky J, Rubenstein A, et al. 1980. Glucose kinetics in leprechaunism: accelerated fasting due to insulin resistance. J. Clin. Endocrinol. Metab. 51:988-94
56. Backeljauw PF, Alves C, Eidson M, Cleveland W, Underwood LE, Davenport ML. 1994. Effect of intravenous insulin-like growth factor I in two patients with leprechaunism. Pediatr. Res. 36:749-54
57. Desbois-Mouthon C, Magre J, Duprey J, Caron M, Blivet-Van Eggelpoel MJ, et al. 1997. Major circadian variations of glucose homeostasis in a patient with Rabson-Mendenhall syndrome and primary insulin resistance due to a mutation (Cys284 → Tyr) in the insulin receptor alpha-subunit. Pediatr. Res. 42:72-77
58. Herrera PL, Huarte J, Sanvito F, Meda P, Orci L, Vassalli JD. 1991. Embryogenesis of the murine endocrine pancreas: early expression of pancreatic polypeptide gene. Development 113:1257-65
59. Mc Evoy RC, Madson KL. 1980. Pancreatic insulin-, glucagon-, and somatostatin-positive islets cell populations during the perinatal development of the rat. II. Changes in hormone content and concentration. Biol. Neonate 38:255-59
60. Yoshinari M, Daikoku S. 1982. Ontogenetic appearance of immunoreactive endocrine cells in rat pancreatic islets. Anat. Embryol. 165:63-70
61. Rall LB, Pictet RL, Rutter WJ. 1979. Synthesis and accumulation of proinsulin and insulin during development of the embryonic rat pancreas. Endocrinology 105:835-41
62. Girard JR, Kervan A, Soufflet E, Assan R. 1973. Factors affecting the secretion of insulin and glucagon by the rat fetus. Diabetes 23:310-17
63. Kervran A, Girard JR. 1974. Glucose induced increase of plasma insulin in the rat fetus in utero. J. Endocrinol. 62:545-51
64. Finegood DT, Scaglia L, Bonner-Weir S. 1995. Dynamics of beta-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes 44:249-56
65. Polak M, Bouchareb-Banaei L, Scharfmann R, Czernichow P. 2000. Early pattern of differentiation in the human pancreas. Diabetes 49:225-32
66. Bocian-Sobkowska J, Zabel M, Wozniak W, Surdyk-Zasada J. 1999. Polyhormonal aspect of the endocrine cells of the human fetal pancreas. Histochem. Cell Biol. 112:147-53
67. Stefan Y, Ravazzola M, Orci L. 1981. Primitive islets contain two populations of cells with differing glucagon immunoreactivity. Diabetes 30:192-95
68. Like AA, Orci L. 1972. Embryogenesis of the human pancreatic islets: a light and electron microscopic study. Diabetes 21:511-34
69. Economides DL, Nicolaides KH, Campbell S. 1991. Metabolic and endocrine findings in appropriate and small for gestational age fetuses. J. Perinat. Med. 19:97-105
70. Longo N, Wang Y, Pasquali M. 1999. Progressive decline in insulin levels in Rabson-Mendenhall syndrome. J. Clin. Endocrinol. Metab. 84:2623-29
71. Roach P, Zick Y, Formisano P, Accili D, Taylor SI, Gorden P. 1994. A novel human insulin receptor gene mutation uniquely inhibits insulin binding without impairing posttranslational processing. Diabetes 43:1096-102
72. Girard J, Ferre P, Pegorier JP, Duee PH. 1992. Adaptations of glucose and fatty acid metabolism during perinatal period and suckling-weaning transition. Physiol. Rev. 72:507-62
73. Di Cola G, Cool MH, Accili D. 1997. Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors. J. Clin. Invest. 99:2538-44
74. Park BC, Kido Y, Accili D. 1999. Differential signaling of insulin and IGF-1 receptors to glycogen synthesis in murine hepatocytes. Biochemistry 38:7517-23
75. Kim JJ, Park BC, Kido Y, Accili D. 2001. Mitogenic and metabolic effects of type IIGF receptor overexpression in in-sulin receptor-deficient hepatocytes. Endocrinology 142:3354-60
76. Rother KI, Imai Y, Caruso M, Beguinot F, Formisano P, Accili D. 1998. Evidence that IRS-2 phosphorylation is required for insulin action in hepatocytes. J. Biol. Chem. 273:17491-97
77. Kulkarni R, Michael M, Kahn C. 2000. Tissue-specific knockouts of the insulin receptor tyrosine kinase. In Genetic Manipulation of Receptor Expression and Function, ed. D Accili, pp. 129-54. New York: Wiley & Sons
78. Ferrannini E, Galvan AQ, Gastaldelli A, Camastra S, Sironi AM, et al. 1999. Insulin: new roles for an ancient hormone. Eur. J. Clin. Invest. 29:842-52
79. Cline GW, Petersen KF, Krssak M, Shen J, Hundal RS, et al. 1999. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N. Engl. J. Med. 341:240-46
80. Bruning JC, Michael MD, Winnay JN, Hayashi T, Horsch D, et al. 1998. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell 2:559-69
81. Lauro D, Kido Y, Castle AL, Zarnowski MJ, Hayashi H, et al. 1998. Impaired glucose tolerance in mice with a targeted impairment of insulin action in muscle and adipose tissue. Nat. Genet. 20:294-98
82. Shefi-Friedman L, Wertheimer E, Shen S, Bak A, Accili D, Sampson SR. 2001. Increased IGFR activity and glucose transport in cultured skeletal muscle from insulin receptor null mice. Am. J. Physiol. Endocrinol. Metab. 281:E16-E24
83. Wojtaszewski JF, Higaki Y, Hirshman MF, Michael MD, Dufresne SD, et al. 1999. Exercise modulates postreceptor insulin signaling and glucose transport in muscle-specific insulin receptor knockout mice. J. Clin. Invest. 104:1257-64
84. Mu J, Brozinick JT Jr, Valladares O, Bucan M, Birnbaum MJ. 2001. A role for AMP-activated protein kinase in contraction-and hypoxia-regulated glucose transport in skeletal muscle. Mol. Cell 7:1085-94
85. Kim JK, Michael MD, Previs SF, Peroni OD, Mauvais-Jarvis F, et al. 2000. Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle. J. Clin. Invest. 105:1791-97
86. Fernandez A, Kim J, Yakar S, Dupont J, Hernandez-Sanchez C, et al. 2001. Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Genes Dev. 15:1926-34
87. Zisman A, Peroni OD, Abel ED, Michael MD, Mauvais-Jarvis F, et al. 2000. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat. Med. 6:924-28
88. Golay A, DeFronzo RA, Ferrannini E, Simonson DC, Thorin D, et al. 1988. Oxidative and non-oxidative glucose metabolism in non-obese type 2 (non-insulin-dependent) diabetic patients. Diabetologia 31:585-91
89. Marin P, Hogh-Kristiansen I, Jansson S, Krotkiewski M, Holm G, Bjorntorp P. 1992. Uptake of glucose carbon in muscle glycogen and adipose tissue triglycerides in vivo in humans. Am. J. Physiol. Endocrinol. Metab. 263:E473-E80
90. Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM. 2000. Transcriptional regulation of adipogenesis. Genes Dev. 14:1293-307
91. Blueher M, Michael M, Peroni O, Ueki K, Carter N, et al. 2002. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev. Cell. 3:35-48
92. Abel ED, Peroni O, Kim JK, Kim YB, Boss O, et al. 2001. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409:729-33
93. Cherrington AD. 1999. Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. Diabetes 48:1198-214
94. Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, et al. 2000. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol. Cell 6:87-97
95. Fisher S, Kahn C. 2001. No evidence for an indirect effect of insulin to suppress glucose production in liver-specific insulin receptor knockout mice. Diabetes 50(Suppl. 2):A50
96. Polonsky KS, Sturis J, Bell GI. 1996. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance. N. Engl. J. Med. 334:777-83
97. Matschinsky FM. 1996. Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes 45:223-41
98. Kulkarni RN, Winnay JN, Daniels M, Bruning JC, Flier SN, et al. 1999. Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines. J. Clin. Invest. 104:R69-75
99. Withers DJ, Sanchez-Gutierrez J, Towery H, Burks DJ, Ren J-M, et al. 1998. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900-4
100. Leibiger B, Leibiger IB, Moede T, Kemper S, Kulkarni RN, et al. 2001. Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic beta cells. Mol. Cell 7:559-70
101. Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR. 1999. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96:329-39
102. Zawalich WS, Zawalich KC. 2000. A link between insulin resistance and hyperinsulinemia: inhibitors of phosphatidylinositol 3-kinase augment glucose-induced insulin secretion from islets of lean, but not obese, rats. Endocrinology 141:3287-95
103. Eto K, Yamashita T, Tsubamoto Y, Terauchi Y, Hirose K, et al. 2002. Phosphatidylinositol 3-kinase suppresses glucose-stimulated insulin secretion by affecting post-cytosolic [Ca(2+)] elevation signals. Diabetes 51:87-97
104. Hirayama I, Tamemoto H, Yokota H, Kubo SK, Wang J, et al. 1999. Insulin receptor-related receptor is expressed in pancreatic beta-cells and stimulates tyrosine phosphorylation of insulin receptor substrate-1 and -2. Diabetes 48:1237-44
105. Kitamura T, Kido Y, Nef S, Merenmies J, Parada LF, Accili D. 2001. Preserved pancreatic beta-cell development and function in mice lacking the insulin receptor-related receptor. Mol. Cell Biol. 21:5624-30
106. Lowell BB, Susulic SV, Hamann A, Lawitts JA, Himms HJ, et al. 1993. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366:740-42
107. Guerra C, Navarro P, Valverde AM, Arribas M, Bruning J, et al. 2001. Brown adipose tissue-specific insulin receptor knockout shows diabetic phenotype without insulin resistance. J. Clin. Invest. 108:1205-13
108. Havrankova J, Roth J, Brownstein M. 1978. Insulin receptors are widely distributed in the central nervous system of the rat. Nature 272:827-29
109. Obici S, Feng Z, Tan J, Liu L, Karkanias G, Rossetti L. 2001. Central melanocortin receptors regulate insulin action. J. Clin. Invest. 108:1079-85
110. Olefsky JM, Kolterman OG, Scarlett JA. 1982. Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. Am. J. Physiol. Endocrinol. Metab. 243:E15-E30
111. Freidenberg GR, Reichart D, Olefsky JM, Henry RR. 1988. Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss. J. Clin. Invest. 82:1398-406
112. Kido Y, Burks DJ, Withers D, Bruning JC, Kahn CR, et al. 2000. Tissue-specific insulin resistance in mice with combined mutations of insulin receptor, IRS-1 and IRS-2. J. Clin. Invest. 105:199-205
113. Bruning JC, Winnay J, Bonner WS, Taylor SI, Accili D, Kahn CR. 1997. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 88:561-72
114. Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, et al. 1994. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372:182-86
115. Araki E, Lipes MA, Patti ME, Bruning JC, Haag BR, et al. 1994. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:186-90
116. Ghosh S, Collins FS. 1996. The geneticist's approach to complex disease. Annu. Rev. Med. 47:333-53
117. Cox NJ, Frigge M, Nicolae DL, Concannon P, Hanis CL, et al. 1999. Loci on chromosomes 2 (NIDDMI) and 15 interact to increase susceptibility to diabetes in Mexican Americans. Nat. Genet. 21:213-15
118. Previs SF, Withers DJ, Ren JM, White MF, Shulman GI. 2000. Contrasting effects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo. J. Biol. Chem. 275:38990-94
119. Terauchi Y, Tsuji Y, Satoh S, Minoura H, Murakami K, et al. 1999. Increased insulin sensitivity and hypoglycaemia in mice lacking the p85 alpha subunit of phosphoinositide 3-kinase. Nat. Genet. 21:230-35
120. Fruman DA, Mauvais-Jarvis F, Pollard DA, Yballe CM, Brazil D, et al. 2000. Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85alpha. Nat. Genet. 26:379-82
121. Mauvais-Jarvis F, Ueki K, Fruman DA, Hirshman MF, Sakamoto K, et al. 2002. Reduced expression of the murine p85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes. J. Clin. Invest. 109: 141-49
122. Gottlieb S, Ruvkun G. 1994. daf-2, daf-16 and dqf-23: genetically interacting genes controlling Dauer formation in Caenorhabditis elegans. Genetics 137:107-20
123. Kimura KD, Tissenbaum HA, Liu Y, Ruvkun G. 1997. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277:942-46
124. Morris JZ, Tissenbaum HA, Ruvkun G. 1996. A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans. Nature 382:536-39
125. Paradis S, Ruvkun G. 1998. Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev. 12:2488-98
126. Ogg S, Paradis S, Gottlieb S, Patterson GI, Lee L, et al. 1997. The Forkhead transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389:994-99
127. Lin K, Dorman JB, Rodan A, Kenyon C. 1997. daf-16: an HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 278:1319-22
128. Lin K, Hsin H, Libina N, Kenyon C. 2001. Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/IGF-1 and germline signaling. Nat. Genet. 28:139-45
129. Kaestner KH, Knochel W, Martinez DE. 2000. Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev. 14:142-46
130. Nakae J, Biggs WI, Kitamura T, Cavanee W, Wright C, et al. 2002. Regulation of insulin action and pancreatic β-cell function by mutant alleles of the forkhead transcription factor Foxol. Nat. Genet. In press